Form 4: GoodRx Holdings Executive Reports Stock Transaction
Insider Transaction (Form 4)
Thomas (Tc) Chan, Chief Accounting Officer of GoodRx Holdings, Inc., reported multiple transactions in common stock on September 15, 2026.
Summary
- Option exercise/conversion: acquired 2,101 Class A Common Stock on September 15, 2026; holds 15,647 after (Direct).
- Tax/exercise-price withholding: disposed of 1,069 Class A Common Stock at $3.56 ($3,806) on September 15, 2026; holds 14,578 after (Direct).
- Option exercise/conversion: disposed of 2,101 Restricted Stock Unit on September 15, 2026; holds 12,606 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Thomas (Tc) Chan — Officer (Chief Accounting Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-15 | Option exercise/conversion | Class A Common Stock | 2,101 | — | — | 15,647 |
| 2026-09-15 | Tax/exercise-price withholding | Class A Common Stock | 1,069 | $4 | $3.8K | 14,578 |
| 2026-09-15 | Option exercise/conversion | Restricted Stock Unit | 2,101 | — | — | 12,606 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-15 | Option exercise/conversion (2,101 shares) |
| 2026-09-15 | Tax/exercise-price withholding (1,069 shares) |
| 2026-09-15 | Option exercise/conversion (2,101 shares) |
Keywords
insider transaction, Form 4, GDRX, GoodRx Holdings, Inc., neutral, Thomas (Tc) Chan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.